CN106177901B - A kind of private parts facial mask - Google Patents
A kind of private parts facial mask Download PDFInfo
- Publication number
- CN106177901B CN106177901B CN201610795789.3A CN201610795789A CN106177901B CN 106177901 B CN106177901 B CN 106177901B CN 201610795789 A CN201610795789 A CN 201610795789A CN 106177901 B CN106177901 B CN 106177901B
- Authority
- CN
- China
- Prior art keywords
- parts
- facial mask
- private
- bifidobacterium
- extract
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 103
- 239000000284 extract Substances 0.000 claims abstract description 73
- 239000007788 liquid Substances 0.000 claims abstract description 53
- 241000186000 Bifidobacterium Species 0.000 claims abstract description 51
- 239000000203 mixture Substances 0.000 claims abstract description 34
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000004745 nonwoven fabric Substances 0.000 claims abstract description 32
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 28
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 claims abstract description 26
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 claims abstract description 23
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 17
- 241000195649 Chlorella <Chlorellales> Species 0.000 claims abstract description 16
- 244000299461 Theobroma cacao Species 0.000 claims abstract description 15
- 235000009470 Theobroma cacao Nutrition 0.000 claims abstract description 15
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 15
- 241000220317 Rosa Species 0.000 claims abstract description 14
- 239000010495 camellia oil Substances 0.000 claims abstract description 14
- 239000008169 grapeseed oil Substances 0.000 claims abstract description 14
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 14
- 239000004310 lactic acid Substances 0.000 claims abstract description 14
- CYDQOEWLBCCFJZ-UHFFFAOYSA-N 4-(4-fluorophenyl)oxane-4-carboxylic acid Chemical compound C=1C=C(F)C=CC=1C1(C(=O)O)CCOCC1 CYDQOEWLBCCFJZ-UHFFFAOYSA-N 0.000 claims abstract description 13
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000005770 Eugenol Substances 0.000 claims abstract description 13
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229920002385 Sodium hyaluronate Polymers 0.000 claims abstract description 13
- 235000021302 avocado oil Nutrition 0.000 claims abstract description 13
- 239000008163 avocado oil Substances 0.000 claims abstract description 13
- 229960002217 eugenol Drugs 0.000 claims abstract description 13
- 229940010747 sodium hyaluronate Drugs 0.000 claims abstract description 13
- 239000001540 sodium lactate Substances 0.000 claims abstract description 13
- 235000011088 sodium lactate Nutrition 0.000 claims abstract description 13
- 229940005581 sodium lactate Drugs 0.000 claims abstract description 13
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 claims abstract description 13
- 239000008367 deionised water Substances 0.000 claims abstract description 12
- 229910021641 deionized water Inorganic materials 0.000 claims abstract description 12
- 229960000271 arbutin Drugs 0.000 claims abstract description 11
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 claims abstract description 11
- 239000010668 rosemary oil Substances 0.000 claims abstract description 10
- 229940058206 rosemary oil Drugs 0.000 claims abstract description 10
- 235000001543 Corylus americana Nutrition 0.000 claims abstract description 9
- 240000007582 Corylus avellana Species 0.000 claims abstract description 9
- 235000007466 Corylus avellana Nutrition 0.000 claims abstract description 9
- 244000088415 Raphanus sativus Species 0.000 claims abstract 4
- 239000002121 nanofiber Substances 0.000 claims description 33
- 239000000853 adhesive Substances 0.000 claims description 15
- 230000001070 adhesive effect Effects 0.000 claims description 15
- 229940002008 bifidobacterium bifidum Drugs 0.000 claims description 15
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 14
- 241000186016 Bifidobacterium bifidum Species 0.000 claims description 14
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 14
- 241001465754 Metazoa Species 0.000 claims description 12
- 240000000249 Morus alba Species 0.000 claims description 10
- 235000008708 Morus alba Nutrition 0.000 claims description 10
- 102000009027 Albumins Human genes 0.000 claims description 7
- 108010088751 Albumins Proteins 0.000 claims description 7
- 210000002950 fibroblast Anatomy 0.000 claims description 7
- 210000002966 serum Anatomy 0.000 claims description 7
- 229920000742 Cotton Polymers 0.000 claims description 4
- 239000003998 snake venom Substances 0.000 claims description 4
- 241000208680 Hamamelis mollis Species 0.000 claims description 3
- 239000004677 Nylon Substances 0.000 claims description 3
- 229920001778 nylon Polymers 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 235000019198 oils Nutrition 0.000 claims description 3
- 229940118846 witch hazel Drugs 0.000 claims description 3
- 229920001131 Pulp (paper) Polymers 0.000 claims description 2
- 229920002678 cellulose Polymers 0.000 claims description 2
- 239000001913 cellulose Substances 0.000 claims description 2
- 244000178231 Rosmarinus officinalis Species 0.000 claims 2
- 101100279438 Caenorhabditis elegans egg-3 gene Proteins 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 239000003292 glue Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 23
- 230000002087 whitening effect Effects 0.000 abstract description 11
- 230000037303 wrinkles Effects 0.000 abstract description 9
- 230000003020 moisturizing effect Effects 0.000 abstract description 8
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 7
- 238000009499 grossing Methods 0.000 abstract description 7
- 230000001954 sterilising effect Effects 0.000 abstract description 7
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 7
- 239000010410 layer Substances 0.000 description 43
- 210000003491 skin Anatomy 0.000 description 29
- 239000004744 fabric Substances 0.000 description 17
- 238000000034 method Methods 0.000 description 17
- 230000000052 comparative effect Effects 0.000 description 16
- 241000220259 Raphanus Species 0.000 description 13
- 230000008569 process Effects 0.000 description 10
- 206010046914 Vaginal infection Diseases 0.000 description 9
- 201000008100 Vaginitis Diseases 0.000 description 9
- 239000000835 fiber Substances 0.000 description 9
- 229920000728 polyester Polymers 0.000 description 9
- 208000004926 Bacterial Vaginosis Diseases 0.000 description 8
- 208000007074 Trichomonas Vaginitis Diseases 0.000 description 7
- 208000025206 Trichomonas vaginitis urogenital infection Diseases 0.000 description 7
- 239000004814 polyurethane Substances 0.000 description 7
- 238000000576 coating method Methods 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 239000011230 binding agent Substances 0.000 description 5
- 239000011248 coating agent Substances 0.000 description 5
- 230000003628 erosive effect Effects 0.000 description 5
- 230000006870 function Effects 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 230000002195 synergetic effect Effects 0.000 description 5
- 210000001215 vagina Anatomy 0.000 description 5
- 229920002955 Art silk Polymers 0.000 description 4
- 239000012790 adhesive layer Substances 0.000 description 4
- 229920002635 polyurethane Polymers 0.000 description 4
- 238000011160 research Methods 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 229930182470 glycoside Natural products 0.000 description 3
- 150000002338 glycosides Chemical class 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 238000007689 inspection Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 229920002239 polyacrylonitrile Polymers 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- 241001656831 Arctous alpina Species 0.000 description 2
- 241000193830 Bacillus <bacterium> Species 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 244000247747 Coptis groenlandica Species 0.000 description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 239000002033 PVDF binder Substances 0.000 description 2
- 239000004697 Polyetherimide Substances 0.000 description 2
- 239000004372 Polyvinyl alcohol Substances 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 229920005654 Sephadex Polymers 0.000 description 2
- 239000012507 Sephadex™ Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 239000004433 Thermoplastic polyurethane Substances 0.000 description 2
- 201000007096 Vulvovaginal Candidiasis Diseases 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 230000003796 beauty Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 239000004568 cement Substances 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 201000010251 cutis laxa Diseases 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 235000013601 eggs Nutrition 0.000 description 2
- 238000010041 electrostatic spinning Methods 0.000 description 2
- 210000004392 genitalia Anatomy 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 229920001477 hydrophilic polymer Polymers 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 230000002045 lasting effect Effects 0.000 description 2
- 230000027939 micturition Effects 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 239000002574 poison Substances 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 229920002451 polyvinyl alcohol Polymers 0.000 description 2
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229920002803 thermoplastic polyurethane Polymers 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- 210000003905 vulva Anatomy 0.000 description 2
- SKIIKRJAQOSWFT-UHFFFAOYSA-N 2-[3-[1-(2,2-difluoroethyl)piperidin-4-yl]oxy-4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]pyrazol-1-yl]-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound FC(CN1CCC(CC1)OC1=NN(C=C1C=1C=NC(=NC=1)NC1CC2=CC=CC=C2C1)CC(=O)N1CC2=C(CC1)NN=N2)F SKIIKRJAQOSWFT-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 244000066764 Ailanthus triphysa Species 0.000 description 1
- 241001134770 Bifidobacterium animalis Species 0.000 description 1
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000011293 Brassica napus Nutrition 0.000 description 1
- 235000000540 Brassica rapa subsp rapa Nutrition 0.000 description 1
- 244000249214 Chlorella pyrenoidosa Species 0.000 description 1
- 235000007091 Chlorella pyrenoidosa Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- JOYRKODLDBILNP-UHFFFAOYSA-N Ethyl urethane Chemical compound CCOC(N)=O JOYRKODLDBILNP-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 1
- 229920002292 Nylon 6 Polymers 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 244000025272 Persea americana Species 0.000 description 1
- 235000008673 Persea americana Nutrition 0.000 description 1
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 1
- 229920012266 Poly(ether sulfone) PES Polymers 0.000 description 1
- 229920000297 Rayon Polymers 0.000 description 1
- 108010013296 Sericins Proteins 0.000 description 1
- 241000270295 Serpentes Species 0.000 description 1
- 244000223014 Syzygium aromaticum Species 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- 229920004933 Terylene® Polymers 0.000 description 1
- 241001502500 Trichomonadida Species 0.000 description 1
- 241000381602 Vachellia nebrownii Species 0.000 description 1
- 208000037009 Vaginitis bacterial Diseases 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- OBNDGIHQAIXEAO-UHFFFAOYSA-N [O].[Si] Chemical compound [O].[Si] OBNDGIHQAIXEAO-UHFFFAOYSA-N 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000002835 absorbance Methods 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 238000007605 air drying Methods 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 229940118852 bifidobacterium animalis Drugs 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- CDQSJQSWAWPGKG-UHFFFAOYSA-N butane-1,1-diol Chemical compound CCCC(O)O CDQSJQSWAWPGKG-UHFFFAOYSA-N 0.000 description 1
- 238000003490 calendering Methods 0.000 description 1
- 238000009960 carding Methods 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 229940113088 dimethylacetamide Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 238000001523 electrospinning Methods 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000001339 epidermal cell Anatomy 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 238000004108 freeze drying Methods 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000004750 melt-blown nonwoven Substances 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000006855 networking Effects 0.000 description 1
- 239000002547 new drug Substances 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000012805 post-processing Methods 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 238000009666 routine test Methods 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 210000000106 sweat gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 230000010148 water-pollination Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/075—Ethers or acetals
- A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/745—Bifidobacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/02—Algae
- A61K36/05—Chlorophycota or chlorophyta (green algae), e.g. Chlorella
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/54—Lauraceae (Laurel family), e.g. cinnamon or sassafras
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/61—Myrtaceae (Myrtle family), e.g. teatree or eucalyptus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/738—Rosa (rose)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/87—Vitaceae or Ampelidaceae (Vine or Grape family), e.g. wine grapes, muscadine or peppervine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/92—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof
- A61K8/922—Oils, fats or waxes; Derivatives thereof, e.g. hydrogenation products thereof of vegetable origin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/99—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Birds (AREA)
- Dermatology (AREA)
- Molecular Biology (AREA)
- Emergency Medicine (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Tropical Medicine & Parasitology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The present invention relates to a kind of private parts facial masks, and it includes non-woven fabric layer, the non-woven fabric layer is impregnated with facial mask liquid；The facial mask liquid contains each component of following parts by weight: 5-10 parts of aurantialba extract, 6-8 parts of chlorella extract, 1-5 parts of radish powder, 1-8 parts of rose extract, 8-10 parts of arbutin, 1-5 parts of echidnotoxin peptide, 2-5 parts of avocado oil, 1-3 parts of cocoa seed extracts, 1-3 parts of Sodium Hyaluronate, 2-5 parts of Rosemary Oil, 1-3 parts of grape seed oil, 1-3 parts of lactic acid, 3-5 parts of sodium lactate, 1-5 parts of eugenol, 2-5 parts of tea oil, 1-4 parts of hazel extract, 1-2 parts of Bifidobacterium composition, 5-15 parts and deionized water 40-78 parts of glycerol.By application private parts facial mask provided by the invention, sterilization and anti-inflammatory can be played the role of, it is non-stimulated to skin, while private parts can also be made to achieve the effect that whitening, moisturizing and smoothing wrinkle.
Description
Technical field
The present invention relates to health care technology fields, and in particular to a kind of facial mask more particularly to a kind of private parts facial mask.
Background technique
Facial mask is temporarily isolating extraneous air and pollution, improves skin mainly using the of short duration time for being covered on skin
Temperature expands the pore of skin, promotes sweat gland secretion and metabolism, increase the oxygen content of skin, is conducive to skin row
Except the product of epidermal cell metabolism and the oil substances of accumulation, the moisture in facial mask penetrates into the cuticula of skin epidermis,
Skin becomes soft, and skin is naturally bright flexible.
According to the form of facial mask, it is generally classified as diaphragm type and emulsion-type two major classes.Diaphragm type facial mask is with plastics system
Make, and is coated with drug, can be wrinkle resistant, dirt is removed, keeps skin vigorous；Emulsion-type facial mask is in paste, is eluted with water after painting, energy
Play the role of extra-nutrition, skin care.According to the effect of facial mask, it is classified as moisturizing facial mask, nourishing pack, anti-drawn grain
Film, curative effect facial mask etc..Whitening mask and mask for acne in curative effect facial mask are that different component is added for yellowish-brown class and acne
Traditional Chinese medicinal components be made.Result of study shows: improving skin in appearance, curative effect facial mask is than general cosmetics and medicine
Object therapeutic effect is big, quick.
The facial mask occurred in the market at present is mainly to be applied to face or skin of neck, and pass through such face of application
Film is mainly used for achieving the effect that beauty.So far, it and has no facial mask applied to private parts, also has no through private parts facial mask
To realize the report for carrying out sterilization and anti-inflammatory to private parts.However, the use of some suppositorys can bring all due in actual therapeutic
Mostly inconvenient, operation is also relative complex, in addition, it is heavy that private parts can generate a large amount of pigment due to inherent cause, hormone secretion etc.
, and there is the phenomenon that cutis laxa, to influence the skin beauty of human body.
It therefore, will be big as can researching and developing a kind of mask product for applying to private parts for realizing sterilization and anti-inflammatory to private parts
Facilitate daily use greatly, operates simpler, conveniently；And by the application private parts facial mask, as can alleviate pigmentation and
Cutis laxa, it will help meet the greater demand of women.
Summary of the invention
In view of problems of the prior art, the purpose of the present invention is to provide a kind of facial masks, in particular, provide one
Kind private parts facial mask can play the role of carrying out private parts sterilization and anti-inflammatory by the application private parts facial mask, stingless to skin
Swash, while private parts can also be made to achieve the effect that whitening, moisturizing and smoothing wrinkle.
For this purpose, the invention adopts the following technical scheme:
The present invention provides a kind of private parts facial masks, and it includes non-woven fabric layer, the non-woven fabric layer is impregnated with face
Film liquid；The facial mask liquid contains each component of following parts by weight:
5-10 parts of aurantialba extract, 6-8 parts of chlorella extract, 1-5 parts of radish powder, 1-8 parts of rose extract, black bearberry
8-10 parts of glycosides, 1-5 parts of echidnotoxin peptide, 2-5 parts of avocado oil, 1-3 parts of cocoa seed extracts, 1-3 parts of Sodium Hyaluronate, fan change
2-5 parts of essential oil, 1-3 parts of grape seed oil, 1-3 parts of lactic acid, 3-5 parts of sodium lactate, 1-5 parts of eugenol, 2-5 parts of tea oil, gold thread
1-4 parts of plum extracting solution, 1-2 parts of Bifidobacterium composition, 5-15 parts of glycerol and 40-78 parts of deionized water.
The present invention can play synergistic work by the way that each component of facial mask liquid is carried out reasonable disposition between each component
With can realize the effect for carrying out sterilization and anti-inflammatory to private parts well, while also private parts can be made to reach whitening, moisturizing and smoothing wrinkle
Effect.
According to the present invention, content (weight) of the aurantialba extract in facial mask liquid is 5-10 parts, such as can be 5
It is specific between part, 5.5 parts, 6 parts, 6.5 parts, 7 parts, 7.5 parts, 8 parts, 8.5 parts, 9 parts, 9.5 parts or 10 parts and above-mentioned numerical value
Point value, as space is limited and for concise consideration, the specific point value that range described in the present invention no longer exclusive list includes.The present invention
Described in the content of aurantialba extract be preferably 6-8 parts, further preferably 6 parts.
According to the present invention, term " aurantialba extract ", which refers to, is extracted by any mode well known in the art from Jin Erzhong
The golden fungus polysaccharides containing effective component extract, such as can be obtained by extraction process.
According to the present invention, content (weight) of the chlorella extract in facial mask liquid is 6-8 parts, such as can be 6
Part, 6.5 parts, 7 parts, 7.5 parts or the specific point value between 8 parts and above-mentioned numerical value, as space is limited and for concise consideration,
The specific point value that range described in the present invention no longer exclusive list includes.The content of heretofore described chlorella extract is preferably
7-8 parts, further preferably 8 parts.
According to the present invention, term " chlorella extract " refers to is mentioned from chlorella by any mode well known in the art
The extract containing effective component taken out, can also be by being commercially available.Illustratively, it such as can be obtained by following technique
: chlorella (chlorella pyrenoidosa) frond 10g is put into butanediol 100mL, agitating and heating, 100 DEG C of heating 2h, is removed not
Molten object obtains freeze-dried powder after liquid is concentrated.
According to the present invention, content (weight) of the radish powder in facial mask liquid be 1-5 parts, such as can be 1 part,
Specific point value between 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts and above-mentioned numerical value, as space is limited
And for concise consideration, specific point value that range described in the present invention no longer exclusive list includes.Heretofore described radish
The content of powder is preferably 2-5 parts, and further preferably 3 parts.
According to the present invention, term " radish powder ", which refers to, processes powdering for radish by any mode well known in the art
Object.Illustratively, it such as can be obtained by following technique: first that fresh radish (carrot tassel powder or green turnip tassel) is clear
After washing, draining surface moisture under room temperature, heated-air drying at 50 DEG C makes moisture content≤7%, is crushed with medicinal herb grinder, mistake
200-300 mesh obtains radish powder.
According to the present invention, content (weight) of the rose extract in facial mask liquid be 1-8 parts, such as can be 1 part,
1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts, 5 parts, 5.5 parts, 6 parts, 6.5 parts, 7 parts, 7.5 parts or 8 parts, Yi Jishang
The specific point value between numerical value is stated, as space is limited and for concise consideration, range described in the present invention no longer exclusive list includes
Specific point value.The content of heretofore described rose extract is preferably 3-6 parts, and further preferably 5 parts.
According to the present invention, term " rose extract " can be prepared by mode commercially available or well known in the art.Show
Example property, such as the 1.1.1 low cost vegetable plant water extract part being referred in document " researchs of Flos Rosae Rugosae extract anti-aging effects "
(" researchs of Flos Rosae Rugosae extract anti-aging effects ", Shao Wei etc., " Nankai University's journal ", the 3rd phase of volume 41, in June, 2008).
According to the present invention, content (weight) of the arbutin in facial mask liquid is 8-10 parts, such as can be 8 parts, 8.5
Part, 9 parts, 9.5 parts or the specific point value between 10 parts and above-mentioned numerical value, as space is limited and for concise consideration, the present invention
The no longer specific point value that includes of range described in exclusive list.The content of heretofore described arbutin is preferably 9-10 parts, into one
Preferably 10 parts of step.
According to the present invention, No. CAS of term " arbutin " is 497-76-7, primarily serves whitening function.
According to the present invention, content (weight) of the echidnotoxin peptide in facial mask liquid be 1-5 parts, such as can be 1 part,
Specific point value between 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts and above-mentioned numerical value, as space is limited
And for concise consideration, specific point value that range described in the present invention no longer exclusive list includes.Heretofore described snake venom egg
The content of white peptide is preferably 2-5 parts, into one preferably 3 parts.
According to the present invention, term " echidnotoxin peptide ", also referred to as " calmette's serum protein peptides " can pass through commercially available or sheet
Mode well known to field is prepared.Illustratively, it such as can be obtained by following technique:
(1) thick poison is produced；
(2) DEAE-Sephadex A-50 is applied, gradient elution is carried out with the buffer containing NaCl, separates snake venom；
(3) the thick poison isolated is used in the Tris-HCl buffer of pH7.5 on 100000rpm refrigerated centrifuge, acquirement
Clear liquid.
(4) above-mentioned supernatant is chromatographed with Sephadex G-75 column, is 240nm in absorbance, protein peak is collected, through ultrafiltration
Concentration, freeze-drying obtain echidnotoxin.
According to the present invention, content (weight) of the avocado oil in facial mask liquid be 2-5 parts, such as can be 2 parts,
Specific point value between 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts and above-mentioned numerical value, as space is limited and for simplicity
The considerations of, specific point value that range described in the present invention no longer exclusive list includes.The content of heretofore described avocado oil is excellent
2-4 parts are selected as, into one preferably 2 parts.
According to the present invention, term " avocado oil ", also referred to as " Butyrospermum parkii oil ", can be public by commercially available or this field
The mode known is prepared.
According to the present invention, content (weight) of the cocoa seed extracts in facial mask liquid is 1-3 parts, such as can be 1
Part, 1.5 parts, 2 parts, 2.5 parts or the specific point value between 3 parts and above-mentioned numerical value, as space is limited and for concise consideration,
The specific point value that range described in the present invention no longer exclusive list includes.The content of heretofore described cocoa seed extracts is preferably
1-2 parts, further preferably 1 part.
According to the present invention, term " cocoa seed extracts " refers to is extracted from cocoa by any mode well known in the art
The extract containing effective component out can also pass through commercially available acquisition.
According to the present invention, content (weight) of the Sodium Hyaluronate in facial mask liquid be 1-3 parts, such as can be 1 part,
Specific point value between 1.5 parts, 2 parts, 2.5 parts or 3 parts and above-mentioned numerical value, as space is limited and for concise consideration, this hair
The specific point value that range described in bright no longer exclusive list includes.The content of heretofore described Sodium Hyaluronate is preferably 1-2 parts,
Further preferably 1 part.
According to the present invention, content (weight) of the Rosemary Oil in facial mask liquid be 2-5 parts, such as can be 2 parts,
Specific point value between 2.5 parts, 3 parts, 3.5 parts, 4 parts, 4.5 parts or 5 parts and above-mentioned numerical value, as space is limited and for simplicity
The considerations of, specific point value that range described in the present invention no longer exclusive list includes.The content of heretofore described Rosemary Oil
Preferably 3-5 parts, further preferably 4 parts.
According to the present invention, content (weight) of the grape seed oil in facial mask liquid be 1-3 parts, such as can be 1 part,
Specific point value between 1.5 parts, 2 parts, 2.5 parts or 3 parts and above-mentioned numerical value, as space is limited and for concise consideration, this hair
The specific point value that range described in bright no longer exclusive list includes.The content of heretofore described grape seed oil is preferably 1-2 parts, into
One step is preferably 2 parts.
According to the present invention, content (weight) of the lactic acid in facial mask liquid be 1-3 parts, such as can be 1 part, 1.5 parts,
Specific point value between 2 parts, 2.5 parts or 3 parts and above-mentioned numerical value, as space is limited and for concise consideration, the present invention is no longer
The specific point value that range described in exclusive list includes.The content of heretofore described lactic acid is preferably 1-2 parts, further preferably
1 part.
According to the present invention, content (weight) of the sodium lactate in facial mask liquid is 3-5 parts, such as can be 3 parts, 3.5
Part, 4 parts, 4.5 parts or the specific point value between 5 parts and above-mentioned numerical value, as space is limited and for concise consideration, the present invention
The no longer specific point value that includes of range described in exclusive list.The content of heretofore described sodium lactate is preferably 4-5 parts, further
Preferably 4 parts.
According to the present invention, content (weight) of the eugenol in facial mask liquid is 1-5 parts, such as can be 1 part, 1.5
Part, 2 parts, 2.5 parts, 3 parts, 4 parts or the specific point value between 5 parts and above-mentioned numerical value being examined as space is limited and for concise
Consider, the specific point value that range described in the present invention no longer exclusive list includes.The content of heretofore described eugenol is preferably 2-5
Part, further preferably 3 parts.
According to the present invention, content (weight) of the tea oil in facial mask liquid is 2-5 parts, such as can be 2 parts, 2.5
Part, 3 parts, 3.5 parts, 4 parts, 4.5 parts or the specific point value between 5 parts and above-mentioned numerical value being examined as space is limited and for concise
Consider, the specific point value that range described in the present invention no longer exclusive list includes.The content of heretofore described tea oil is preferably 3-5
Part, further preferably 4 parts.
According to the present invention, content (weight) of the hazel extract in facial mask liquid is 1-4 parts, such as can be 1
Part, 1.5 parts, 2 parts, 2.5 parts, 3 parts, 3.5 parts or the specific point value between 4 parts and above-mentioned numerical value, as space is limited and for letter
Bright consideration, the specific point value that range described in the present invention no longer exclusive list includes.Heretofore described hazel extract
Content is preferably 2-4 parts, and further preferably 3 parts.
According to the present invention, term " Sodium Hyaluronate ", " Rosemary Oil ", " grape seed oil ", " lactic acid ", " sodium lactate ",
" eugenol ", " tea oil " and " hazel extract " is each meant to be contained by what any mode well known in the art extracted
The extract of ingredient or the product of commercially available acquisition are imitated, particular determination is not done to its specific preparation method.
According to the present invention, content (weight) of the Bifidobacterium composition in facial mask liquid is 1-2 parts, such as be can be
1 part, 1.1 parts, 1.2 parts, 1.3 parts, 1.4 parts, 1.5 parts, 1.6 parts, 1.7 parts, 1.8 parts, 1.9 parts or 2 parts and above-mentioned numerical value it
Between specific point value, as space is limited and for concise consideration, range described in the present invention no longer exclusive list includes specific
Value.The content that heretofore described Bifidobacterium group is combined into is preferably 1-1.5 parts, and further preferably 1.5 parts.
According to the present invention, the Bifidobacterium composition is preferably using following combination: by bifidobacterium lactis
(Bifidobacterium lactis), animal bifidobacteria (Bifidobacterium animalis) and bifidobacterium bifidum
(Bifidobacterium bifidum) composition；Wherein, the weight ratio between above-mentioned each Bifidobacterium is (according to above-mentioned each bifid
The sequence of bacillus) it is specially (3-5): (1-3): (2-7), such as can be 3:1:2,4:1:5,5:1:3,4:2:7,5:1:6,4:
1:5 or 5:1:7, preferably 5:1:3.
Present invention employs increase on the basis of various extracts Bifidobacterium composition as facial mask liquid it is active at
Point, which create synergistic functions, can balance each flora in vagina well, have wide spectrum for treatment vaginitis
Property simultaneously can fundamentally prevent and treat vaginitis disease.
Inventor is it was unexpectedly observed that the present invention is used cooperatively by using by three kinds of Bifidobacteriums, compared to using single
One component can be further improved the effective percentage of the prevention and treatment to various vaginitis diseases, wherein it is for colpomycosis and drop
The treated effect of worm property vaginitis can be improved to 99.5%, for the treated effect of cervical erosion and bacterial vaginitis
It can reach 99.1% or more.
According to the present invention, content (weight) of the glycerol in facial mask liquid is 5-15 parts, such as can be 5 parts, 6 parts, 7
Part, 7.5 parts, 8 parts, 9 parts, 10 parts, 11 parts, 12 parts, 13 parts, 14 parts or the specific point value between 15 parts and above-mentioned numerical value, limit
In length and for concise consideration, specific point value that range described in the present invention no longer exclusive list includes.It is heretofore described
The content of glycerol is preferably 5-10 parts, and further preferably 8 parts.
According to the present invention, content (weight) of the deionized water in facial mask liquid is 40-78 parts, such as can be 40
Part, 41 parts, 45 parts, 48 parts, 50 parts, 52 parts, 55 parts, 58 parts, 60 parts, 62 parts, 63 parts, 65 parts, 68 parts, 70 parts, 72 parts, 73
Part, 75 parts or the specific point value between 78 parts and above-mentioned numerical value, as space is limited and for concise consideration, the present invention is no longer
The specific point value that range described in exclusive list includes.The content of deionized water of the present invention is preferably 42-75 parts, further excellent
It is selected as 51 parts.
According to the present invention, the private parts facial mask, preferably comprises each component of following parts by weight:
6-8 parts of aurantialba extract, 7-8 parts of chlorella extract, 2-5 parts of radish powder, 3-6 parts of rose extract, black bearberry
9-10 parts of glycosides, 2-5 parts of echidnotoxin peptide, 2-4 parts of avocado oil, 1-2 parts of cocoa seed extracts, 1-2 parts of Sodium Hyaluronate, fan change
3-5 parts of essential oil, 1-2 parts of grape seed oil, 1-2 parts of lactic acid, 4-5 parts of sodium lactate, 2-5 parts of eugenol, 3-5 parts of tea oil, gold thread
2-4 parts of plum extracting solution, 1-1.5 parts of Bifidobacterium composition, 5-10 parts of glycerol and 42-75 parts of deionized water.
It is further preferred that the facial mask liquid is grouped as by each group of following parts by weight:
6 parts of aurantialba extract, 8 parts of chlorella extract, 3 parts of radish powder, 5 parts of rose extract, 10 parts of arbutin, snake
3 parts of toxalbumin peptide, avocado oily 2 parts, 1 part of cocoa seed extracts, 1 part of Sodium Hyaluronate, 4 parts of Rosemary Oil, grape seed oil 2
Part, 1 part of lactic acid, 4 parts of sodium lactate, 3 parts of eugenol, 4 parts of tea oil, 3 parts of hazel extract, 1.5 parts of Bifidobacterium composition,
8 parts and 51 parts of deionized water of glycerol.
According to the present invention, the non-woven fabric layer is the substrate for being impregnated with the facial mask of facial mask liquid.Non-woven fabric layer does not have
Have and particularly limit, precondition is made of it by supatex fabric commonly used in the art.For the leaching for being conducive to facial mask liquid
Stain, the supatex fabric comprising hydrophilic fibre are preferred.The hydrophilic fibre can be selected from following objects to be at least one
Matter: mulberry silk, cotton, paper pulp, nylon, cellulose, etc..
In the present invention, the non-woven fabric layer also may include the polymer of such as polyester (PET), easy to handle to ensure
Property, processability, etc..
The complex nonwoven fabric layer being made of hydrophilic fibre and polymer can be non-woven comprising artificial silk and PET
Tissue layer.In this case, the weight ratio of artificial silk and PET can be at (7-8): (5-3), preferably (7-8): (8-2), more preferably
For 7:8.
Non-woven fabric layer according to supatex fabric manufacturing process can for meltblown nonwoven fabric, spunbonded non-woven fabrics,
Hydroentangled nonwoven fabrics, etc., however, the present invention is not limited thereto.
As used herein, the term " supatex fabric " be include random orientation plurality of fibers web.Here, this
A little fibers can be staple fiber or continuous filaments.
Total weight of the content of non-woven fabric layer based on facial mask can be in the range of 96.5 weight % to 99 weight %.
The thickness of non-woven fabric layer is not particularly limited, but can be in the range of 0.32mm to 0.38mm.Non-woven fabric layer
The quality of per unit area is not particularly limited, but can be in the range of 45gsm to 55gsm.
According to the present invention, the private parts facial mask also contains layers of nanofibers, is adhered on the non-woven fabric layer；It is excellent
Selection of land, by adhesive phase, fusible films plus heat or ultrasonic between the layers of nanofibers and the non-woven fabric layer
Any one mode is bonded.
In the present invention, the layers of nanofibers is used as the adhesive surface of skin.Non-woven fabric layer is present in relatively
In on the apparent surface of the facial mask of the adhesive surface of skin, if any, described adhesive layer is clipped between the two.
Layers of nanofibers since the Kong Zhongke that nanofiber can be easily accessible skin shows excellent skin adhesion, and
Nanoscale fiber enhances the reservation of liquid side film liquid in which can dramatically.
Layers of nanofibers in the present invention includes hydrophilic polymer, is used as the adhesive surface of skin.It can be used
Hydrophilic polymer in the present invention can be selected from following substance: polyacrylonitrile (PAN), hydrophilic polyurethane to be at least one
(PU), polyvinyl alcohol (PVA), nylon (nylon 6), hydrophily polyvinylidene fluoride (PVDF), hydrophilic polyethersulfone (PES) and poly-
Etherimide (PEI), etc..The layers of nanofibers also may include thermoplastic polyurethane (TPU), be adhered to skin with enhancing
When flexibility and prevent due to outer friction or contact (for example, scratch or fracture) damage to the layers of nanofibers.
Total weight of the content of the layers of nanofibers based on the facial mask can be in 0.7 weight % to 2.8 weight %'s
In range, and the quality of the per unit area of the layers of nanofibers can be in the range of 0.4gsm to 2gsm according to gas permeability
It is interior.
To ensure more preferably skin adhesion in the use process of facial mask and liquid make-up preparation to the good of skin
Infiltration, the pore size of the layers of nanofibers can be in the range of 0.8 μm to 3 μm, and the diameter of single nanofiber can be
In the range of 100nm to 300nm.The thickness of layers of nanofibers non-specifically limits, but it can be in 0.5 μm to 2 μm of range.
In the present invention, the layers of nanofibers is bonded to non-woven fabric layer.Non-woven fabric layer and the nanofiber
Bonding between layer is formed using selected from following one or more of modes: adhesive phase, adds thermally or ultrasonically fusible films
Wave.For example, the layers of nanofibers by acquisitions such as electrostatic spinnings can be adhered using adhesive to non-woven fabric layer, alternatively, receiving
Rice fiber can be on the non-woven fabric layer that coats to adhesive of electrostatic spinning.
Private parts facial mask of the invention may include that at least one being placed between non-woven fabric layer and layers of nanofibers is added
Layer, can be adhesive layer.At least one adhesive can be used as adhesive phase.
Workable adhesive phase can be by acryloid cement, polyurethane binder, polyester binder, silicon oxygen in the present invention
Alkane adhesive or combinations thereof is made.The use of acryloid cement, polyurethane binder and polyester binder is preferred.
Described adhesive can prevent nanofiber to be layered and the minimum without skin irritatin uses.In general,
Total weight of the content of described adhesive layer based on the facial mask can be in the range of 0.05 weight % to 0.5 weight %.
Utilize method generally known in the art, such as coating method, evaporation (deposition) method etc., described adhesive layer
It can be formed on non-woven fabric layer.
The supatex fabric of nanofiber coating is subjected to post-processing generally known in the art (calendering process) to prepare
Facial mask of the invention.
According to the present invention, the layers of nanofibers contains the fibroblast factor and human serum albumins, can play
Continue the effect of whitening and smoothing wrinkle.
The present invention also provides foregoing private parts facial masks to dispel the purposes in private parts wrinkle and/or moisturizing, can also
For private parts whitening.
Compared with prior art, the present invention at least has the advantages that
(1) present invention can play synergy between each component by the way that each component of facial mask liquid is carried out reasonable disposition
Effect, each flora in vagina can be balanced well, having for treatment vaginitis broad spectrum activity and can fundamentally prevent
Control vaginitis disease；It can be improved to 99.5% the treated effect of colpomycosis and trichomonas vaginitis, right
It can reach 99.1% or more in the treated effect of cervical erosion and bacterial vaginitis；
(2) by application private parts facial mask provided by the invention, can not only play the role of sterilization and anti-inflammatory, to skin without
Stimulation, while private parts can also be made to achieve the effect that lasting whitening, moisturizing and smoothing wrinkle.
Specific embodiment
Of the invention for ease of understanding, it is as follows that the present invention enumerates embodiment.Those skilled in the art are it will be clearly understood that the implementation
Example is only to aid in the understanding present invention, should not be regarded as a specific limitation of the invention.
Embodiment 1
(1) raw material is weighed according to following weight, is uniformly mixed, prepare facial mask liquid:
Aurantialba extract 6g, chlorella extract 8g, radish powder 3g, rose extract 5g, arbutin 10g, snake venom egg
White peptide 3g, avocado oil 2g, cocoa seed extracts 1g, Sodium Hyaluronate 1g, Rosemary Oil 4g, grape seed oil 2g, lactic acid 1g,
Sodium lactate 4g, eugenol 3g, tea oil 4g, hazel extract 3g, Bifidobacterium composition 1.5g, glycerol 8g and deionized water
51g；
Wherein the weight ratio of the bifidobacterium lactis in Bifidobacterium composition, animal bifidobacteria and bifidobacterium bifidum is
5:1:3；
(2) preparation of mulberry silk nourishing pack spunlace non-woven cloth: the mulberry silk 100kg after choosing removal of impurities is removed through F108
Miscellaneous carding machine combing, removes impurity and short flannel, obtains 92kg fine work mulberry silk fiber；Combing, networking through spun lacing production line, water
Thorn；Through with 80g/m2Plain weave terylene non-woven fabric wrapped up roller dryer (drum temperature be 70 DEG C, speed of production 18
M/min, finished product weight is 60g/m2) drying；It batches and cuts into 25cm breadth to get 75kg nourishing pack patch mulberry silk spun lacing is arrived
Non-woven fabrics base fabric, the active sericin content of the cloth is up to 5% or more；
(3) after mulberry silk nourishing pack to be cut into the facial mask size for needing size with spunlace non-woven cloth, it is immersed in step
(1) in facial mask liquid；Mulberry silk nourishing pack spunlace non-woven cloth and the mass volume ratio of facial mask liquid are 1g:20mL, when immersion
Between be 30min, be made private parts facial mask.
Embodiment 2
(1) raw material is weighed according to each component in embodiment 1, be uniformly mixed, prepare facial mask liquid；
(2) the artificial silk PET of viscose rayon and PET (weight ratio 8:2) (Nanyang Textile Co., Ltd.) will be included
Spun lacing (60gsm) is prepared as supatex fabric；Polyurethane binder (0.3g) is coated on the supatex fabric poly- to be formed
The artificial silk PET water non-woven fabric of urethane adhesive coating；By PAN (6.30g), parent in dimethyl acetamide (89.5g)
The solution of aqueous PU (3.15g), heat fusing PU (1.04g) and pigment (0.01g) is applied to the adhesive by electrospinning process
On the supatex fabric of coating, to complete the supatex fabric of nanofiber coating；At this point, the per unit of the layers of nanofibers
The Mass adjust- ment of area is 1gsm；Wherein, the 1.5g fibroblast factor and 1.2g human seralbumin egg are contained in layers of nanofibers
It is white；
(3) after the supatex fabric that nanofiber coats being cut into the facial mask size for needing size, it is immersed in step (1)
Facial mask liquid in；The supatex fabric of nanofiber coating and the mass volume ratio of facial mask liquid are 1g:20mL, and soaking time is
Private parts facial mask is made in 30min.
Embodiment 3
Compared with Example 1, other same as Example 1 in addition to the component of facial mask liquid and its content are different.
Raw material is weighed according to following weight, is uniformly mixed, facial mask liquid is prepared:
Aurantialba extract 8g, chlorella extract 7g, radish powder 5g, rose extract 3g, arbutin 9g, echidnotoxin
Peptide 2g, avocado oil 4g, cocoa seed extracts 2g, Sodium Hyaluronate 2g, Rosemary Oil 5g, grape seed oil 1g, lactic acid 2g, cream
Sour sodium 5g, eugenol 2g, tea oil 3g, hazel extract 4g, Bifidobacterium composition 1g, glycerol 5g and deionized water 65g；
Wherein the weight ratio of the bifidobacterium lactis in Bifidobacterium composition, animal bifidobacteria and bifidobacterium bifidum is
5:1:3。
Embodiment 4
Compared with Example 1, other same as Example 1 in addition to the component of facial mask liquid and its content are different.
Raw material is weighed according to following weight, is uniformly mixed, facial mask liquid: aurantialba extract 10g, chlorella extract is prepared
6g, radish powder 1g, rose extract 2g, arbutin 8g, echidnotoxin peptide 2g, avocado oil 2g, cocoa seed extracts 3g, thoroughly
Bright matter acid sodium 1g, Rosemary Oil 2g, grape seed oil 1g, lactic acid 1g, sodium lactate 3g, eugenol 1g, tea oil 2g, witch hazel mention
Take liquid 1g, Bifidobacterium composition 2g, glycerol 10g and deionized water 45g；
Wherein the weight ratio of the bifidobacterium lactis in Bifidobacterium composition, animal bifidobacteria and bifidobacterium bifidum is
5:1:3。
Embodiment 5
Compared with Example 1, other with 1 phase of embodiment in addition to the weight ratio of ingredient each in Bifidobacterium composition is different
Together.
The weight ratio of bifidobacterium lactis, animal bifidobacteria and bifidobacterium bifidum in Bifidobacterium composition is 3:1:
7。
Embodiment 6
Compared with Example 1, other same as Example 1 in addition to the weight ratio of each ingredient of Bifidobacterium composition is different.
The weight ratio of bifidobacterium lactis, animal bifidobacteria and bifidobacterium bifidum in Bifidobacterium composition is 4:3:
5。
Embodiment 7
Compared with Example 1, other same as Example 1 in addition to mulberry silk nourishing pack is replaced with cotton.
Comparative example 1
Compared with Example 1, other same as Example 1 in addition to being added without Bifidobacterium composition.
Comparative example 2
Compared with Example 1, except bifidobacterium lactis, animal bifidobacteria and bifidobacterium bifidum in Bifidobacterium composition
Weight ratio be 1:4:1 outside, it is other same as Example 1.
Comparative example 3
Compared with Example 1, except bifidobacterium lactis, animal bifidobacteria and bifidobacterium bifidum in Bifidobacterium composition
Weight ratio be 6:1:8 outside, it is other same as Example 1.
Comparative example 4
Compared with Example 1, in addition to Bifidobacterium composition is using the single Bifidobacterium of bifidobacterium lactis, other and implementation
Example 1 is identical.
Comparative example 5
Compared with Example 1, except Bifidobacterium composition is using in addition to the single Bifidobacterium of animal bifidobacteria, it is other with it is real
It is identical to apply example 1.
Comparative example 6
Compared with Example 1, except Bifidobacterium composition is using in addition to the single Bifidobacterium of bifidobacterium bifidum, it is other with it is real
It is identical to apply example 1.
Comparative example 7
Compared with Example 2, other in addition to not containing the fibroblast factor and human serum albumins in layers of nanofibers
It is same as Example 2.
Comparative example 8
Compared with Example 2, in addition to containing human serum albumins in layers of nanofibers and not containing the fibroblast factor,
It is other same as Example 2.
Comparative example 9
Compared with Example 2, in addition to containing the fibroblast factor in layers of nanofibers and not containing human serum albumins,
It is other same as Example 2.
Comparative example 10
Compared with Example 1, except being added without Sodium Hyaluronate, Rosemary Oil, grape seed oil, lactic acid, sodium lactate, cloves
These are organized exceptionally for phenol, tea oil and hazel extract, other same as Example 1.
Comparative example 11
Compared with Example 1, except being added without aurantialba extract, chlorella extract, radish powder, rose extract, bear
These are organized exceptionally for fruit glycosides, echidnotoxin peptide, avocado oil and cocoa seed extracts, other same as Example 1.
Clinical test
One, research method
Research approach is referring to related " the gynemetrics's genital inflammation of Ministry of Health of the People's Republic of China's new drug clinical guidance principle
The clinical verification of local application " content and formulate.
1. test case: accepting patient totally 150 for medical treatment, make a definite diagnosis bacterial vaginitis patient 50 through gynecologial examination, beads
Bacterium property vulvovaginal patient 53；Trichomonas vaginitis patient 47, the age between 21-60 years old, excludes gestation and feeds
Newborn phase patient；
2. diagnostic criteria:
Symptom: pruritus vulvue, cusalgia, or with frequent micturition, urgent urination, urodynia；
Gynecologial examination: bacterial vaginitis secretory substance is even, thin, has a fish like smell；Vulvovaginal candidiasis, have compared with
More white bean dregs sample leukorrhea；Trichomonas vaginitis secretion is in yellow foam；
Laboratory checks: bacterial vaginitis can discover a clue under microscope cell in secretion, monilial vulva
Vaginopathy, smear detect, and look for pseudohypha under microscope, positive rate is up to 60%；Trichomonas vaginitis vaginal fluid microscope
Under visible trichomonad；
3. grouping and application vagina facial mask: by 51 cervical erosion, being randomly divided into treatment group 29 and control group 22；It will
50 bacterial vaginitis are randomly divided into treatment group 29 and control group 21；By 53 vulvovaginal candidiasis patients,
It is randomly divided into treatment group 33 and control group 20；By 47 trichomonas vaginitis patients, it is randomly divided into treatment group 25 and right
According to group 22；The vagina facial mask of application embodiment 1-7 and comparative example 1-11 are given by the above treatment group, and a daily patch, 7 days are one
The course for the treatment of；
4. observation item
4.1 therapeutic observations
(1) symptom；
(2) gynecologial examination: including vulva, vagina, uterine neck and vaginal fluid inspection；
(3) laboratory check: to vaginal fluid inspection, including under mirror, smear；
(4) Bacteria Culture；
4.2 safety observations
(1) general physical examination project；
(2) blood, urine, feces routine test；
(3) heart, Liver and kidney function inspection；
4.3 adverse reactions observation
Any abnormal symptom occurred during medication, sign, laboratory checks, all answers serious analysis, carefully identifies；
4.4 skin irritatins test
5. efficacy assessment standard:
Recovery from illness: symptom disappears, and gynecologial examination and laboratory check normally；
Effective: symptom is substantially reduced, and gynecologial examination and laboratory check and be clearly better；
Effective: symptom is mitigated, and gynecologial examination and laboratory check and improved；
It is invalid: unchanged before relatively being treated after treatment；
6. treatment results: after patient's 4 courses for the treatment of of equal application, therapeutic effect is as shown in table 1.
Table 1
It can be seen from Table 1 that embodiment 1 is by addition Bifidobacterium composition and adopts compared with comparative example 1 and 4-6
The facial mask liquid constituted is compounded with by bifidobacterium lactis, animal bifidobacteria and bifidobacterium bifidum, compared to using individually a kind of double
Discrimination bacillus or the case where do not add, for colpomycosis and trichomonas vaginitis and cervical erosion and bacterial vaginosis
Scorching treated effect is improved, and illustrates that this these three Bifidobacterium produces synergistic function；With comparative example 2-3 phase
Than embodiment 1 can greatly improve private parts by using the facial mask liquid for setting the weight ratio of three kinds of Bifidobacteriums to 5:1:3
Therapeutic effect of the facial mask to various vaginitis；Compared with comparative example 7-9, embodiment 2 in layers of nanofibers by being added into fibre
Cell factor and human serum albumins component are tieed up, private parts facial mask is can aid in and cures various vaginitis, the fibroblast factor
There is synergistic function between human serum albumins both components, improve treated effect；With comparative example 10-11 phase
Than embodiment 1 has synergistic function by using the sum of these components to each other, controls various vaginitis are improved
Therapeutic effect has obvious effect.
The private parts film sample prepared in embodiment 1-7 is applied to 30min on the genital skin surface of 20 people, and is seen
The presence of skin irritatin (for example, itch, inflammation) is examined, and compares the whitening skin degree and guarantor before application and after application
Wet degree.Test result is shown, does not find skin irritatin phenomenon in 20 people, illustrates that the private parts facial mask pacifies application on human skin very much
Entirely；In addition to this, it was found that the trend that there is the private parts after application pigment to shoal illustrates that it makees with a degree of whitening
With；In addition, also having certain moisturizing and smoothing wrinkle effect after application.
It in summary it can be seen, private parts facial mask provided by the invention, for controlling for colpomycosis and trichomonas vaginitis
Treating effective percentage can be improved to 99.5%, can reach 99.1% for the treated effect of cervical erosion and bacterial vaginitis
More than；Moreover, can not only play the role of sterilization and anti-inflammatory, while can also by application private parts facial mask provided by the invention
Private parts is set to achieve the effect that lasting whitening, moisturizing and smoothing wrinkle.
The Applicant declares that the present invention is explained by the above embodiments detailed process equipment and process flow of the invention,
But the present invention is not limited to the above detailed process equipment and process flow, that is, it is above-mentioned detailed not mean that the present invention must rely on
Process equipment and process flow could be implemented.It should be clear to those skilled in the art, any improvement in the present invention,
Addition, selection of concrete mode of equivalence replacement and helper component to each raw material of product of the present invention etc., all fall within of the invention
Within protection scope and the open scope.
Claims (11)
1. a kind of private parts facial mask, which is characterized in that it includes non-woven fabric layer, the non-woven fabric layer is impregnated with facial mask
Liquid；The facial mask liquid contains each component of following parts by weight:
5-10 parts of aurantialba extract, 6-8 parts of chlorella extract, 1-5 parts of radish powder, 1-8 parts of rose extract, arbutin 8-
10 parts, 1-5 parts of echidnotoxin peptide, 2-5 parts of avocado oil, 1-3 parts of cocoa seed extracts, 1-3 parts of Sodium Hyaluronate, rosemary essence
2-5 parts oily, 1-3 parts of grape seed oil, 1-3 parts of lactic acid, 3-5 parts of sodium lactate, 1-5 parts of eugenol, 2-5 parts of tea oil, witch hazel mention
Take 1-4 parts of liquid, 1-2 parts of Bifidobacterium composition, 5-15 parts of glycerol and 40-78 parts of deionized water.
2. private parts facial mask as described in claim 1, which is characterized in that the facial mask liquid contains each component of following parts by weight:
6-8 parts of aurantialba extract, 7-8 parts of chlorella extract, 2-5 parts of radish powder, 3-6 parts of rose extract, arbutin 9-
10 parts, 2-5 parts of echidnotoxin peptide, 2-4 parts of avocado oil, 1-2 parts of cocoa seed extracts, 1-2 parts of Sodium Hyaluronate, rosemary essence
3-5 parts oily, 1-2 parts of grape seed oil, 1-2 parts of lactic acid, 4-5 parts of sodium lactate, 2-5 parts of eugenol, 3-5 parts of tea oil, witch hazel mention
Take 2-4 parts of liquid, 1-1.5 parts of Bifidobacterium composition, 5-10 parts of glycerol and 42-75 parts of deionized water.
3. private parts facial mask as claimed in claim 1 or 2, which is characterized in that the facial mask liquid by following parts by weight each component
Composition:
6 parts of aurantialba extract, 8 parts of chlorella extract, 3 parts of radish powder, 5 parts of rose extract, 10 parts of arbutin, snake venom egg
3 parts of white peptide, avocado oil 2 parts, 1 part of cocoa seed extracts, 1 part of Sodium Hyaluronate, 4 parts of Rosemary Oil, 2 parts of grape seed oil,
It is 1 part of lactic acid, 4 parts of sodium lactate, 3 parts of eugenol, 4 parts of tea oil, 3 parts of hazel extract, 1.5 parts of Bifidobacterium composition, sweet
8 parts and 51 parts of deionized water of oil.
4. private parts facial mask as described in claim 1, which is characterized in that the Bifidobacterium composition is by bifidobacterium lactis, dynamic
Object Bifidobacterium and bifidobacterium bifidum composition.
5. private parts facial mask as claimed in claim 4, which is characterized in that bifidobacterium lactis in the Bifidobacterium composition,
The weight ratio of animal bifidobacteria and bifidobacterium bifidum is (3-5): (1-3): (2-7).
6. private parts facial mask as claimed in claim 4, which is characterized in that bifidobacterium lactis in the Bifidobacterium composition,
The weight ratio of animal bifidobacteria and bifidobacterium bifidum is 5:1:3.
7. private parts facial mask as described in claim 1, which is characterized in that the non-woven fabric layer be cotton, mulberry silk, paper pulp,
In nylon or cellulose any one or at least two mixture.
8. private parts facial mask as described in claim 1, which is characterized in that the non-woven fabric layer is cotton and/or mulberry silk.
9. private parts facial mask as described in claim 1, which is characterized in that the private parts facial mask also contains layers of nanofibers, glues
It is connected on the non-woven fabric layer.
10. private parts facial mask as claimed in claim 9, which is characterized in that the layers of nanofibers and the non-woven fabric layer
Between by adhesive phase, fusible films, plus heat or ultrasonic in any one mode be bonded.
11. private parts facial mask as claimed in claim 9, which is characterized in that the layers of nanofibers contains the fibroblast factor
And human serum albumins.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610795789.3A CN106177901B (en) | 2016-08-31 | 2016-08-31 | A kind of private parts facial mask |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610795789.3A CN106177901B (en) | 2016-08-31 | 2016-08-31 | A kind of private parts facial mask |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106177901A CN106177901A (en) | 2016-12-07 |
| CN106177901B true CN106177901B (en) | 2019-06-11 |
Family
ID=58085622
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610795789.3A Active CN106177901B (en) | 2016-08-31 | 2016-08-31 | A kind of private parts facial mask |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106177901B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107432890B (en) * | 2017-08-16 | 2020-12-25 | 宁波七悦科技有限公司 | PH-sensitive type female care product and preparation method thereof |
| CN107456509B (en) * | 2017-08-30 | 2018-11-02 | 海南鸿昇生物药械有限公司 | A kind of external application biological agent and preparation method for vagina prevention, health care and treatment gynaecology genital inflammation |
| CN108938517A (en) * | 2018-08-16 | 2018-12-07 | 肖渭强 | A kind of women privates care composition, preparation method and nursing film |
| CN109674671A (en) * | 2019-01-07 | 2019-04-26 | 广州市拓瑞科技有限公司 | The preparation method of vaginal care composition object and its application and the women secret conditioning liquid comprising it and women secret conditioning liquid |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102697702B (en) * | 2012-06-08 | 2013-04-17 | 钟春燕 | Whitening and moisturizing repair body membrane and preparation method |
| CN105581921A (en) * | 2014-10-24 | 2016-05-18 | 胡伟杰 | Skin moisturizer for repairing skin |
| CN104873427A (en) * | 2015-05-22 | 2015-09-02 | 周维新 | Anti-wrinkle mask |
-
2016
- 2016-08-31 CN CN201610795789.3A patent/CN106177901B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN106177901A (en) | 2016-12-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106177901B (en) | A kind of private parts facial mask | |
| Shahverdi et al. | Fabrication and structure analysis of poly (lactide-co-glycolic acid)/silk fibroin hybrid scaffold for wound dressing applications | |
| Li et al. | Bioactive electrospun nanoyarn-constructed textile dressing patches delivering Chinese herbal compound for accelerated diabetic wound healing | |
| US10682257B2 (en) | Biological fiber composite dressing | |
| CN105437667A (en) | Preparation method of composite base material for facial masks | |
| CN102677392B (en) | Production technology of biochemical hydrophilic silk non-woven fabric | |
| CN109457392A (en) | A kind of preparation method and the soft towel of cotton of the soft towel of cotton | |
| CN108978042A (en) | A kind of ventilative medical magneto-theapy elastic non-woven cloth of high water absorption height | |
| CN109577016A (en) | A kind of method and application of micro emulsion atomizing spraying technique preparation skin care non-woven fabrics | |
| KR20080028214A (en) | Functional fabric prepared by using persimmon juice and a preparation method thereof | |
| CN109550154A (en) | A kind of minerals as traditional Chinese medicine composition can increase human epidermal infiltration function and its application | |
| CN113403752B (en) | Preparation method of sericin reinforced silk non-woven fabric | |
| CN117883370A (en) | Hydrogel of traditional Chinese medicine freeze-dried powder loaded with keratin and oxidized hyaluronic acid and application thereof | |
| CN104800881B (en) | Biological fiber film and its preparing method | |
| CN108452374A (en) | A kind of spider silk composition and preparation method thereof | |
| Chandrasekaran et al. | Analysis of eco-friendly medicinal herb extracts and essential oil applications on textile products for healthcare applications | |
| DE102004002990A1 (en) | Material especially for medicinal or cosmetic skin treatment has nanoscalar structures and nano- or micro-scalar internal spaces allowing exchange, transfer or storage of e.g. fluids | |
| JP6059264B2 (en) | Biological fiber composite dressing material | |
| CN109602633A (en) | The skincare material and its preparation method and application of soybean fiber mixture viscose rayon | |
| CN109589290A (en) | A kind of plant essence liquid and load have skin care non-woven fabrics of plant essence liquid and preparation method thereof | |
| CN209154630U (en) | A kind of medical dressing | |
| CN110278919A (en) | A method of building vermiform mite causes acne rosacea sample skin lesion animal model | |
| CN110141678A (en) | A kind of alginates physical therapy liquid dressing and preparation method thereof | |
| CN109303703A (en) | A kind of moulding face lift object and application thereof | |
| CN109602681A (en) | Application of the leech body surface secretion in preparation anti-inflammatory anti-acne skin care item |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20211116 Address after: 150040 office building 7, Bohai Third Road, haping road concentration area, Harbin Economic Development Zone, Harbin, Heilongjiang Province Patentee after: Harbin Tianmei Pharmaceutical Co.,Ltd. Address before: 150069 No. 7, Bohai Third Road, Pingfang Industrial Zone, economic and Technological Development Zone, Harbin, Heilongjiang Province Patentee before: HARBIN OT PHARMACEUTICALS Co.,Ltd. Patentee before: Qiu Mingshi |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A pudendal facial mask Effective date of registration: 20230704 Granted publication date: 20190611 Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd. Pledgor: Harbin Tianmei Pharmaceutical Co.,Ltd. Registration number: Y2023230000060 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
| PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20190611 Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd. Pledgor: Harbin Tianmei Pharmaceutical Co.,Ltd. Registration number: Y2023230000060 |
|
| PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
| PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A pudendal facial mask Granted publication date: 20190611 Pledgee: Harbin Kechuang Financing Guarantee Co.,Ltd. Pledgor: Harbin Tianmei Pharmaceutical Co.,Ltd. Registration number: Y2024230000040 |
|
| PE01 | Entry into force of the registration of the contract for pledge of patent right |